Concord Biotech Limited — Sirolimus Exporter Profile
Indian Pharmaceutical Exporter · #11 for Sirolimus · $232.7K export value · DGFT Verified
Concord Biotech Limited is the #11 Indian exporter of Sirolimus with $232.7K in export value and 28 verified shipments. Concord Biotech Limited holds a 1.2% market share in Sirolimus exports across 2 countries. The company exports 3 pharmaceutical products worth $6.9M across 1 therapeutic categories.
Concord Biotech Limited — Sirolimus Export Profile: Buyers & Destinations
Where Does Concord Biotech Limited Export Sirolimus?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $174.1K | 37 | 76.3% |
| IRELAND | $54.2K | 3 | 23.7% |
Concord Biotech Limited exports Sirolimus to 2 countries. The largest destination is UNITED STATES accounting for 76.3% of Concord Biotech Limited's Sirolimus shipments. These destinations reflect Concord Biotech Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sirolimus from Concord Biotech Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SMALL ANIMAL CLINICAL SERVICES | UNITED STATES | $173.8K | 12 |
| DEREK GRUBB | IRELAND | $54.2K | 3 |
| ARGENTA GLOBAL | UNITED STATES | $99 | 12 |
| NC STATE UNIVERSITY COLLEGE | UNITED STATES | $45 | 6 |
| UC DAVIS VETERINARY CENTER | UNITED STATES | $45 | 6 |
| STERN LABORATORY. | UNITED STATES | $24 | 1 |
Concord Biotech Limited supplies Sirolimus to 6 buyers globally. The largest buyer is SMALL ANIMAL CLINICAL SERVICES (UNITED STATES), followed by DEREK GRUBB (IRELAND) and ARGENTA GLOBAL (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sirolimus Export Value and How Much Does Concord Biotech Limited Contribute?
India exported $6.1M worth of Sirolimus through 1,244 shipments from 97 suppliers to 48 countries, serving 128 buyers globally. Concord Biotech Limited contributes $232.7K to this total, accounting for 1.2% of India's Sirolimus exports. Concord Biotech Limited ships Sirolimus to 2 countries through 6 buyers.
What Is the Average Shipment Value for Concord Biotech Limited's Sirolimus Exports?
Concord Biotech Limited's average Sirolimus shipment value is $8.3K per consignment, based on 28 shipments totaling $232.7K. The largest destination is UNITED STATES (76.3% of Concord Biotech Limited's Sirolimus exports).
How Does Concord Biotech Limited Compare to Other Indian Sirolimus Exporters?
Concord Biotech Limited ranks #11 among 97 Indian Sirolimus exporters with a 1.2% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($2.7M), ZYDUS LIFESCIENCES LIMITED ($1.6M), DR REDDYS LABORATORIES LIMITED ($400.0K). Concord Biotech Limited processed 28 shipments to 2 destination countries.
What Sirolimus Formulations Does Concord Biotech Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Sirolimus Rapamycin Delayed Release Tablets 2.4mg BATCH NO.RB23001A / MANUFACTURING .DT.:02-Aug-23 / RETEST DT. Jan 2025 | $55.1K | 2 |
| Sirolimus Rapamycin Delayed Release Tablets 1.2mg BATCH NO.RB23001A / MANUFACTURING .DT.:02-Aug-23 / RETEST DT. Jan 2025 | $51.7K | 2 |
| Placebo of Sirolimus RapamycinDelayedRelease Tablets 2.4mg BATCH NO.PV23001A/ MANUFACTURING .DT.:22-Jun-23 / RETEST DT. May 2026 | $29.2K | 2 |
| Sirolimus Rapamycin Delayed Release Tablets 2.4mg B.NO: RD23001B-R MANUFACTURING .DT:26-Jun-23 RETEST DT. May 2026 | $23.4K | 1 |
| Sirolimus Rapamycin Delayed Release Tablets 1.2mg B.NO: RC23001B-R MANUFACTURING .DT:02-Aug-23 RETEST DT. Jul 2025 | $18.8K | 1 |
| Sirolimus Rapamycin Delayed Release Tablets 0.4mg BATCH NO.RB23001A / MANUFACTURING .DT.:02-Aug-23 / RETEST DT. Jan 2025 | $16.5K | 2 |
| Sirolimus Rapamycin Delayed Release Tablets 0.4mg B.NO: RB23001B-R MANUFACTURING .DT:02-Aug-23 RETEST DT. Jan 2025 | $11.9K | 1 |
| Placebo of Sirolimus RapamycinDelayedRelease Tablets 0.4mg BATCH NO.SA23001A/ MANUFACTURING .DT.:26-Jun-23 / RETEST DT. May 2026 | $11.1K | 2 |
| Placebo of Sirolimus RapamycinDelayedRelease Tablets 1.2mg BATCH NO.PU23001A/ MANUFACTURING .DT.:23-Jun-23 / RETEST DT. May 2026 | $10.2K | 2 |
| SIROLIMUS (RAPAMYCIN) DELAYED RELEASE TABLETS 0.4MG, B.NO. RB23001A, MFG.DT. 02-AUG-23, RETEST DT. JAN 2025NOS | $26 | 2 |
Concord Biotech Limited exports 28 distinct Sirolimus formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Sirolimus Rapamycin Delayed Release Tablets 2.4mg BATCH NO.R with 2 shipments worth $55.1K.
Regulatory Requirements: Exporting Sirolimus to Key Markets
What Concord Biotech Limited must comply with to export Sirolimus to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Concord Biotech Limited Compare to Nearest Sirolimus Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | CONCORD BIOTECH LTD | $178.3K | 12 | 1 | $14.9K |
| 10 | DERRIC WOOD | $89.2K | 675 | 2 | $132 |
| 11 | CONCORD BIOTECH LIMITED ★ | $54.4K | 28 | 2 | $1.9K |
| 12 | SAMEEKSHA PHARMACEUTICALS PRIVATE LIMITED | $18.8K | 3 | 1 | $6.3K |
Concord Biotech Limited ranks #11 among 97 Indian Sirolimus exporters. Average shipment value of $1.9K compared to the market average of $62.9K. The closest competitors by value are CONCORD BIOTECH LTD and DERRIC WOOD.
Which Indian Ports Ship Sirolimus Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 384 | 30.9% |
| DELHI AIR | 234 | 18.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 185 | 14.9% |
| SAHAR AIR | 95 | 7.6% |
| Delhi Air | 64 | 5.1% |
| NHAVA SHEVA SEA (INNSA1) | 36 | 2.9% |
| AHEMDABAD AIR | 29 | 2.3% |
| Bombay Air | 25 | 2.0% |
What Other Immunosuppressants Products Does Concord Biotech Limited Export?
Concord Biotech Limited also exports these immunosuppressants products. Each links to the detailed product page.
About Concord Biotech Limited
Concord Biotech Limited exports 3 products worth $6.9M. Beyond Sirolimus, top products include Mycophenolate, Cyclosporine. View the complete Concord Biotech Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sirolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sirolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Concord Biotech Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 40 individual customs records matching Concord Biotech Limited exporting Sirolimus, covering 28 formulations to 2 countries via 6 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 48+ countries, 128+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sirolimus Export Data from Concord Biotech Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Concord Biotech Limited's Sirolimus exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Concord Biotech Limited
Full Company Profile →
3 products · $6.9M total trade · 1 categories
Sirolimus Stats
Company Overview
Top Products by Concord Biotech Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Concord Biotech Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sirolimus. For current shipment-level data, contact TransData Nexus.